GlassScriptPhysician profile
Shane Michael Pearce
NPI 1518253988
$39,794.53
in general payments reported to CMS, 2019-2025
37 companies · $36K in 2025
The $36K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $200 · 2021: $564 · 2022: $465 · 2023: $870 · 2024: $970 · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $2,788 · Travel and Lodging: $2,007 · Education: $5.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,044.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,880.00 |
| Food and Beverage | $2,787.89 |
| Travel and Lodging | $2,007.14 |
| Education | $5.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $27,088.69 | 2020-2025 | Rybrevant, Carvykti, Erleada |
| Janssen Scientific Affairs, LLC | $8,520.82 | 2023-2025 | Erleada |
| Janssen Global Services, LLC | $500.00 | 2025 | |
| Karl Storz Endoscopy-America | $399.65 | 2019-2021 | |
| Urogen Pharma, INC. | $386.59 | 2021-2024 | Jelmyto |
| Ferring Pharmaceuticals INC. | $373.15 | 2024 | Adstiladrin |
| Abbvie INC. | $352.85 | 2019-2025 | |
| Astellas Pharma US INC | $227.25 | 2019-2023 | Xtandi |
| Photocure INC | $195.61 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $178.16 | 2023-2025 | Gemtesa |
| Rochester Medical Corporation | $174.91 | 2021-2022 | |
| Boston Scientific Corporation | $174.65 | 2021-2024 | Lumenis Pulse 120h |
| Koelis INC. | $163.60 | 2023 | |
| Amgen INC. | $147.32 | 2019 | |
| Merck Sharp & Dohme LLC | $126.38 | 2019-2025 | Keytruda, Keytruda Qlex, Lynparza |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $112.06 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $100.90 | 2021-2025 | Provenge |
| Intuitive Surgical, INC. | $95.32 | 2023 | |
| Pfizer INC. | $77.75 | 2019-2025 | |
| Foundation Medicine, INC. | $66.29 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.52 | 2019-2020 | |
| Bioprotect Medical, INC. | $45.15 | 2025 | Bioprotect Balloon Implant System |
| Endo Pharmaceuticals INC. | $34.99 | 2021-2023 | Xiaflex |
| Coloplast Corp | $30.23 | 2021-2022 | |
| Palette Life Sciences, INC. | $29.24 | 2022 | |
| Telix Pharmaceuticals | $19.86 | 2025 | Illuccix |
| Cardinal Health 414 LLC | $18.37 | 2025 | |
| Olympus America INC. | $15.09 | 2022 | |
| Immunitybio, INC. | $14.78 | 2025 | |
| Verity Pharmaceuticals INC. | $14.63 | 2023 | Trelstar |
| Ethicon US, LLC | $14.50 | 2019 | |
| Allergan, INC. | $14.44 | 2021 | |
| Tolmar, INC. | $13.93 | 2023 | |
| Ambu INC. | $13.21 | 2022 | |
| Travere Therapeutics, INC. | $7.64 | 2021-2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Pearce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.